News

Somite Therapeutics Announces Round Extension with Astellas Venture Management and Montage Ventures Joining as Board Observers

Toregem BioPharma raises 15 Oku-yen through Series B funding round and Grant from the Japan Agency for Medical Research and Development

Shinobi Therapeutics Secures $59M Grant from the Japanese Agency for Medical Research and Development

Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology

Panasonic and Shinobi Therapeutics Partner to Develop Efficient and Cost-Effective iPS Cell Therapy Manufacturing Technology

NeoPhore raises an additional £9.6m (USD $12.2m) Series B financing extension to further progress drug discovery pipeline

Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform

Astellas and MBC BioLabs Announce 2023 Future Innovator Prize Awarded to TippingPoint Biosciences and Altay Therapeutics

Mogrify extends Series A financing to $46 million USD, co-led by Astellas Venture Management and Parkwalk Advisors with participation from other internal investors

Solu Therapeutics Debuts with $31 Million in Seed Funding to Unlock Antibody-Intractable Cell Surface Targets

Toregem BioPharma raises 3.8 Oku-yen Series A2

NeoPhore completes extension to Series B financing to further advance discovery pipeline

Avilar Therapeutics Increases Financing to $75 Million to Advance Pipeline of Novel Extracellular Protein Degraders

Astellas and MBC BioLabs Announce 2022 Future Innovator Prize Awarded to Bespoke Biotherapeutics and Cellinfinity Bio